Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

ACE inhibition in cardiovascular disease.

Francis GS.

N Engl J Med. 2000 Jan 20;342(3):201-2. No abstract available.

PMID:
10639547
[PubMed - indexed for MEDLINE]
2.

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.

Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G.

N Engl J Med. 2000 Jan 20;342(3):145-53. Erratum in: 2000 May 4;342(18):1376. N Engl J Med 2000 Mar 9;342(10):748.

PMID:
10639539
[PubMed - indexed for MEDLINE]
Free Article
3.

Ramipril.

Smith WH, Ball SG.

Int J Clin Pract. 2000 May;54(4):255-60. Review.

PMID:
10912316
[PubMed - indexed for MEDLINE]
4.
5.

Reduction of cardiovascular events and microvascular complications in diabetes with ACE inhibitor treatment: HOPE and MICRO-HOPE.

Gerstein HC.

Diabetes Metab Res Rev. 2002 Sep-Oct;18 Suppl 3:S82-5. Review.

PMID:
12324991
[PubMed - indexed for MEDLINE]
6.

Ramipril: a review of its use in preventing cardiovascular outcomes in high-risk patients.

Anderson VR, Perry CM, Robinson DM.

Am J Cardiovasc Drugs. 2006;6(6):417-32. Review.

PMID:
17192135
[PubMed - indexed for MEDLINE]
7.

What are 'tissue ACE inhibitors,' and should they be used instead of other ACE inhibitors?

Francis GS, Gassler JP.

Cleve Clin J Med. 2001 Mar;68(3):185-6. No abstract available.

PMID:
11263844
[PubMed - indexed for MEDLINE]
8.

Diabetes and the HOPE study: implications for macrovascular and microvascular disease.

Gerstein HC.

Int J Clin Pract Suppl. 2001 Jan;(117):8-12.

PMID:
11715357
[PubMed - indexed for MEDLINE]
9.

The Heart Outcomes Prevention Evaluation study: angiotensin-converting enzyme inhibitors: are their benefits a class effect or do individual agents differ?

Sica DA.

Curr Opin Nephrol Hypertens. 2001 Sep;10(5):597-601. Review.

PMID:
11496052
[PubMed - indexed for MEDLINE]
10.

Don't keep that ACE (inhibitor) up your sleeve! Is ramipril effective for secondary prevention of cardiovascular disease and stroke?

Hammett DC, MacFadyen JC.

Can Fam Physician. 2000 Apr;46:821-3. No abstract available.

PMID:
10790814
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

ACE inhibitors and high-risk patients.

Myers KA.

CMAJ. 2000 Aug 8;163(3):327. No abstract available.

PMID:
10951738
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

[Experiences with the realisation of the innovative study designs using the example of the HOPE study -- concerning the contribution in DMW Supplement 2/2005].

Traut V.

Dtsch Med Wochenschr. 2005 Nov 25;130(47):2726; author reply 2727-8. German. No abstract available.

PMID:
16294292
[PubMed - indexed for MEDLINE]
13.

Cardiovascular risk in patients with mild renal insufficiency: implications for the use of ACE inhibitors.

Mann JF.

Presse Med. 2005 Oct 22;34(18):1303-8. Review.

PMID:
16269994
[PubMed - indexed for MEDLINE]
Free Article
14.

[Vascular patient with high infarction risk. Does the AT-1 blocker protect as well as an ACE inhibitor?].

[No authors listed]

MMW Fortschr Med. 2003 Dec 18;145(51-52):39. German. No abstract available.

PMID:
14974331
[PubMed - indexed for MEDLINE]
15.

A safe new dose of heart protection. Study shows drug can prevent attacks, strokes.

Comarow A.

US News World Rep. 1999 Nov 22;127(20):76. No abstract available.

PMID:
10623306
[PubMed - indexed for MEDLINE]
17.
18.

[Achieving vascular protection. ACE inhibitor lowers not only blood pressure].

[No authors listed]

MMW Fortschr Med. 2001 Sep 6;143(35-36):44-5. German. No abstract available.

PMID:
11584529
[PubMed - indexed for MEDLINE]
19.

Effect of long-term therapy with ramipril in high-risk women.

Lonn E, Roccaforte R, Yi Q, Dagenais G, Sleight P, Bosch J, Suhan P, Micks M, Probstfield J, Bernstein V, Yusuf S; HOPE Investigators. Heart Outcomes Prevention Evaluation.

J Am Coll Cardiol. 2002 Aug 21;40(4):693-702.

PMID:
12204499
[PubMed - indexed for MEDLINE]
20.

Ramipril in the treatment of vascular diseases.

Rokoss MJ, Teo KK.

Expert Opin Pharmacother. 2005 Sep;6(11):1911-9. Review.

PMID:
16144510
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk